Prof. Myrra Vernooij-Dassen (the Netherlands)

Professor Myrra Vernooij-Dassen has been trained as a medical sociologist. She is former director of Radboud Alzheimer Center and emeritus professor in psychosocial aspects of care for frail elderly people. She is a member of the Scientific Advisory Board of the European Joint Programme Neurodegenerative Diseases (JPND) and Chair of the IPA Webinar Series. She has a special interest in social health in relation to dementia.

Paola Barbarino (United Kingdom)

Paola Barbarino is CEO of Alzheimer’s Disease International. Prior to this, she was CEO of LIFE and occupied senior positions with Cass Business School, Tate, British Library and IIED. She is a Board Member of the World Dementia Council, a Trustee of The Postal Museum and of Lauderdale House. Previously she was a Non-Executive Director of the Non-Communicable Disease Alliance (NCDA), a Trustee of Shelter, the housing/homelessness charity, and of MLA London. She holds a degree cum laude in Classics from Federico II Napoli University, an MA in Field and Analytical Techniques in Archaeology and an MA in Library and Information Science both from University College London.

Dr. Jeff Cummings (United States)

Dr. Cummings is the Director of the Chambers-Grundy Center for Transformative Neuroscience at the University of Nevada Las Vegas (UNLV). He is a neurologist and a clinical trialist who led many clinical trials and drug development programs. He has had neurological leadership positions at the University of California Los Angeles (UCLA), the Cleveland Clinic, and UNLV. His research embraces studying the Alzheimer’s drug development pipeline and the influence of biomarkers on drug development.

Moderator: Edgardo Reich, MD
IPA Debate Series- Program Organizer 
Hospital Julo Mendez, Universidad de Buenos Aires 
ARGENTINA

Moderator: Raimundo Mateos, MD, PhD
IPA Debate Series- Program Organizer
Universidad de Santiago de Compostela 
SPAIN